Toward an integrated knowledge environment to support modern oncology

Cancer Journal

Volumn 17, Issue 4, 2011, Pages 257-263

  Blake, Patrick M ^a   Decker, David A ^b,c   Glennon, Timothy M ^a   Liang, Yong Michael ^a   Losko, Sascha ^d   Navin, Nicholas ^e,f   Suh, K Stephen ^g  

^a Sophic Systems Alliance Inc   (United States)

^b FLORIDA HOSPITAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA   (United States)

^d Biomax Informatics AG   (Germany)

^e HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g Department of Genetics Bioinformatics and Computational Biology ^*  (United States)

Author keywords

biomarkers; Informatics; integration; knowledge environment; next generation sequencing; oncology; outcomes; patient; treatment

Indexed keywords

CANCER CENTER; CLINICAL RESEARCH; DEMOGRAPHY; ELECTRONIC MEDICAL RECORD; INTEGRATED KNOWLEDGE ENVIRONMENT; KNOWLEDGE; MEDICAL INFORMATION SYSTEM; ONCOLOGY; PATIENT CARE; PRIORITY JOURNAL; REVIEW;

BIOMEDICAL RESEARCH; DATABASES AS TOPIC; HUMANS; KNOWLEDGE BASES; MEDICAL INFORMATICS; MEDICAL ONCOLOGY; OUTCOME ASSESSMENT (HEALTH CARE); SEQUENCE ANALYSIS, DNA; THERAPEUTICS;

EID: 80051755297     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e31822c390b     Document Type: Review

References (49)

1. Losko S, Wenger K, Kalus W, et al. Knowledge networks of biological and medical data: an exhaustive and flexible solution to model life science domains. Lecture notes in computer science. Data Integr Life Sci. 2006;4075:232-239. (Pubitemid 44165792)
2. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science. 2001;291:1304-1351. (Pubitemid 32173090)
3. Schuler GD, Boguski MS, Stewart EA, et al. A gene map of the human genome. Science. 1996;274:540-546. (Pubitemid 26360428)
4. Martin DB, Nelson PS. From genomics to proteomics: techniques and applications in cancer research. Trends Cell Biol. 2001;11:S60-S65.
5. Kallioniemi OP. Biochip technologies in cancer research. Ann Med. 2001;33:142-147.
6. Strausberg RL, Greenhut SF, Grouse LH, et al. In silico analysis of cancer through the Cancer Genome Anatomy Project. Trends Cell Biol. 2001;11:S66-S71.
7. Claverie JM. Computational methods for the identification of differential and coordinated gene expression. Hum Mol Genet. 1999;8:1821-1832.
8. Cannon GC. Sequence analysis on microcomputers. Science. 1987;238:97-103.
9. Kelly MJ. Computers: the best friends a human genome ever had. Genome. 1989;31:1027-1033. (Pubitemid 20118510)
10. Hertz GZ, Stormo GD. Identifying DNA and protein patterns with statistically significant alignments of multiple sequences. Bioinformatics. 1999;15:563-577. (Pubitemid 29462105)
11. Rechid R, Vingron M, Argos P. A new interactive protein sequence alignment program and comparison of its results with widely used algorithms. Comput Appl Biosci. 1989;5:107-113. (Pubitemid 19111824)
12. Vingron M, Argos P. A fast and sensitive multiple sequence alignment algorithm. Comput Appl Biosci. 1989;5:115-121. (Pubitemid 19111825)
13. Murata M, Richardson JS, Sussman JL. Simultaneous comparison of three protein sequences. Proc Natl Acad Sci U S A. 1985;82:3073-3077. (Pubitemid 15029547)
14. Boguski MS. Bioinformatics. Curr Opin Genet Dev. 1994;4:383-388. (Pubitemid 24195867)
15. Lucas K, Busch M, Mossinger S, et al. An improved microcomputer program for finding gene-or gene family-specific oligonucleotides suitable as primers for polymerase chain reactions or as probes. Comput Appl Biosci. 1991;7:525-529.
16. Omenn GS. Genetic advances will influence the practice of medicine: examples from cancer research and care of cancer patients. Genet Med. 2002;4:15SY20S.
17. Nevins JR, Huang ES, Dressman H, et al. Towards integrated clinicogenomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Hum Mol Genet. 2003;12:R153-R157. Spec no. 2. (Pubitemid 37259327)
18. Rosell R, Monzo M, O'Brate A, et al. Translational oncogenomics: toward rational therapeutic decision-making. Curr Opin Oncol. 2002;14:171-179. (Pubitemid 34235050)
19. Kim JY, Lewandrowski K. Point-of-care testing informatics. Clin Lab Med. 2009;29:449-461.
20. Corn M. Archiving the phenome: clinical records deserve long-term preservation. J Am Med Inform Assoc. 2009;16:1-6.
21. Wright A, Chen ES, Maloney FL. An automated technique for identifying associations between medications, laboratory results and problems. J Biomed Inform. 2010;43:891-901.
22. Brokel JM, Harrison MI. Redesigning care processes using an electronic health record: a system's experience. Jt Comm J Qual Patient Saf. 2009;35:82-92.
23. Roukema J, Los RK, Bleeker SE, et al. Paper versus computer: feasibility of an electronic medical record in general pediatrics. Pediatrics. 2006;117:15-21. (Pubitemid 46050514)
24. Hayrinen K, Saranto K, Nykanen P. Definition, structure, content, use and impacts of electronic health records: a review of the research literature. Int J Med Inform. 2008;77:291-304. (Pubitemid 351434604)
25. Poissant L, Pereira J, Tamblyn R, et al. The impact of electronic health records on time efficiency of physicians and nurses: a systematic review. J Am Med Inform Assoc. 2005;12:505-516. (Pubitemid 41215620)
26. Ferreira A, Antunes L, Chadwick D, et al. Grounding information security in healthcare. Int J Med Inform. 2010;79:268-283.
27. Burgener E. EMR data recovery can be challenging. Newer dataprotection technologies can help address the more stringent recovery requirements driven by EMR implementations. Health Manag Technol. 2010;31:13.
28. Malin B, Airoldi E. Confidentiality preserving audits of electronic medical record access. Stud Health Technol Inform. 2007;129:320-324.
29. Haux R. Health information systemsVpast, present, future. Int J Med Inform. 2006;75:268-281.
30. Zhu CS, Pinsky PF, Cramer DW, et al. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila). 2011;4:375-383.
31. Cramer DW, Bast RC Jr, Berg CD, et al. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila). 2011;4:365-374.
32. Taparowsky E, Suard Y, Fasano O, et al. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature. 1982;300:762-765. (Pubitemid 13224357)
33. Food and Drug Administration. Guidance for Industry Clinical Trial Endpoint for the Approval of Cancer Drugs and Biologics. 2007. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm071590.pdf.
34. Altar CA, Amakye D, Bounos D, et al. A prototypical process for creating evidentiary standards for biomarkers and diagnostics. Clin Pharmacol Ther. 2008;83:368-371.
35. Lim MD, Dickherber A, Compton CC. Before you analyze a human specimen, think quality, variability, and bias. Anal Chem. 2011;83:8-13.
36. Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer. 2005;5:845-856. (Pubitemid 41746029)
37. Grade M, Hormann P, Becker S, et al. Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. Cancer Res. 2007;67:41-56. (Pubitemid 46142758)
38. Ding L, Ellis MJ, Li S et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature. 2010;464:999-1005.
39. Mardis ER, Ding L, Dooling DJ, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med. 2009;361:1058-1066.
40. Russnes HG, Vollan HK, Lingjaerde OC et al. Genomic architecture characterizes tumor progression paths and fate in breast cancer patients. Sci Transl Med. 2010;2:38-47.
41. Shah SP, Morin RD, Khattra J, et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature. 2009;461:809-813.
42. Stephens PJ, McBride DJ, Lin M-L, et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature. 2009;462:1005-1010.
43. Navin N, Kendall J, Troge J, et al. Tumour evolution inferred by singlecell sequencing. Nature. 2011;472:90-94.
44. Navin N, Krasnitz A, Rodgers L, et al. Inferring tumor progression from genomic heterogeneity. Genome Res. 2010;20:68-80.
45. Torres L, Ribeiro FR, Pandis N, et al. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases. Breast Cancer Res Treat. 2007;102:143-155. (Pubitemid 46452166)
46. Shipitsin M, Campbell LL, Argani P, et al. Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007;11:259-273. (Pubitemid 46349843)
47. Berners-Lee T, Hendler J, Lassila O. The Semantic Web. Sci Am. 2001;284:34-43.
48. Goble C, Stevens R. State of the nation in data integration for bioinformatics. J Biomed Inform. 2008;41:687-693.
49. Maier D, Kalus W, Wolff M, et al. Knowledge management for systems biology a general and visually driven framework applied to translational medicine. BMC Syst Biol. 2011;5:38.